C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof

Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
11/1994
11/23/1994	EP0625191A1 Mycobacterial species-specific reporter mycobacteriophages
11/17/1994	EP0624188A1 Novel adherent and invasive mycoplasma
11/15/1994	US5364933 Methods of immunopurification of antigens of human immunodeficiency virus type 2 (HIV-2)
11/15/1994	US5364783 Retrovirus promoter-trap vectors
11/15/1994	US5364757 Methods of supporting a diagnosis of systemic lupus erythematosus
11/10/1994	WO1994025627A1 Methods of treating and detecting cancer using viruses
11/10/1994	WO1994025572A1 Mycobacterial species-specific reporter mycobacteriophages
11/10/1994	WO1994025073A1 Recombinant viruses and their use in gene therapy
11/10/1994	WO1994025064A1 Hepatitis c virus cell propagation and related methods
11/10/1994	WO1994024959A1 Method of detecting compounds utilizing chemically modified lambdoid bacteriophage
11/10/1994	WO1994024870A1 Retroviral vectors capable of expressing multimeric proteins from multiple translational initiation sites
11/10/1994	WO1994024864A1 Methods of preventing viral replication
11/10/1994	WO1994023048A3 Gibbon ape leukemia virus-based retroviral vectors
11/10/1994	WO1994013812A3 Novel entomopoxvirus genes, proteins and methods of use thereof
11/10/1994	DE4314998A1 Monoclonal antibodies against filamentous phages, their preparation and use for detecting and isolating the phages
11/10/1994	CA2162056A1 Retroviral vectors capable of expressing multimeric proteins from multiple translational initiation sites
11/10/1994	CA2161679A1 Recombinant virus and their use in genic therapy
11/10/1994	CA2161671A1 Methods of treating and detecting cancer using viruses
11/10/1994	CA2159716A1 Method of detecting compounds utilizing chemically modified lambdoid bacteriophage
11/09/1994	EP0623172A1 Marek's disease virus recombinant poxvirus vaccine
11/09/1994	EP0623167A1 Preparation of mystery disease virus antigens and vaccines and antigens and vaccines produced for the prevention of this disease
11/08/1994	CA1332919C Viral vaccine
11/02/1994	EP0621790A1 Attenuated, live vaccine for delaware strain ibdv
11/02/1994	EP0506714B1 Matrix with adherently bound cells and process for producing viruses/virus antigens
11/01/1994	US5360605 Preservation of blood, tissues and biological fluids
10/1994
10/27/1994	WO1994024299A1 Adenovirus for the transfer of foreign dna into higher eucaryotic cells
10/27/1994	WO1994024297A1 Defective recombinant adenoviruses for gene therapy of tumours
10/27/1994	WO1994024268A1 Recombinant avian adenovirus vector
10/27/1994	WO1994023756A1 Neural thread protein gene expression and detection of alzheimer's disease
10/27/1994	WO1994023582A1 Adenoviral vectors including dna encoding lung surfactant protein
10/27/1994	CA2161097A1 Neural thread protein gene expression and detection of alzheimer's disease
10/27/1994	CA2160136A1 Adenoviral vectors including dna encoding lung surfactant protein
10/25/1994	US5359045 DNA sequence encoding a polypeptide including nucleic acid encoding amino acids 361-404 and 951-1002
10/19/1994	EP0619840A1 Pseudorabies virus vaccine
10/19/1994	CN1093751A Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof
10/13/1994	WO1994023048A2 Gibbon ape leukemia virus-based retroviral vectors
10/13/1994	WO1994023047A1 Biological control agents containing mollusc toxins
10/13/1994	WO1994023031A1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof
10/13/1994	WO1994023019A1 Novel polypeptide, dna coding for said polypeptide, recombinant vector containing said dna, recombinant virus prepared using said vector, and use thereof
10/12/1994	EP0619117A2 Use of acemannan
10/11/1994	US5354678 Production of recombinant adeno-associated virus vectors
10/11/1994	US5354674 Method of gene transfer using retrotransposons
10/05/1994	EP0617737A1 Method for selecting recombinant micro-organisms of which the surface comprises at least one molecule having enzymatic activity.
10/04/1994	US5352596 Deletion and insertion is in an overlapping region of early protein O gene and the large latency transcript gene
10/04/1994	US5352451 Biological insect control agents and methods of use
09/1994
09/29/1994	WO1994022014A1 Parvovirus receptors and methods of use
09/29/1994	WO1994021808A1 Process for preparing cancer vaccines
09/29/1994	WO1994021807A2 Defective mutant non-retroviral virus (e.g. hsv) as vaccine
09/29/1994	WO1994021792A2 Inhibition of selected tumor growth with recombinant viral vectors
09/29/1994	CA2158655A1 Process for preparing cancer vaccines
09/29/1994	CA2158564A1 Parvovirus receptors and methods of use
09/29/1994	CA2158546A1 Inhibition of selected tumor growth with recombinant viral vectors
09/29/1994	CA2158148A1 Defective mutant non-retroviral virus (e.g. hsv) as vaccine
09/28/1994	EP0616640A1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage
09/21/1994	EP0616031A2 Bovine ovary cell line (FROv) for virus multiplication
09/15/1994	WO1994020146A1 Recombinant adenoviruses and use thereof in gene therapy for treating eye diseases
09/15/1994	WO1994020137A1 Production of human papillomavirus capsid protein and virus-like particles
09/15/1994	CA2154355A1 Recombinant virus and their use in gene therapy
09/14/1994	EP0614979A1 Hog cholera virus vaccine and diagnostic
09/14/1994	EP0614969A2 Use of Herpes saimiri transformed lymphocytes in a process of multiplication of immune deficiency inducing virus of the HIV type
09/14/1994	EP0614465A1 HYBRID PROTEIN BETWEEN CS FROM PLASMODIUM AND HBsAG
09/14/1994	EP0339040B1 Swine dysentery vaccine
09/13/1994	CA2118843A1 Use of lymphocytes transformed with herpesvirus saimiri on a process for replicating viruses of the hiv type which cause immune deficiency
09/06/1994	US5344774 Human intracisternal A-type retroviral particles associated with sjogren's syndrome
09/01/1994	WO1994019478A1 Production of high titer helper-free retroviruses by transient transfection
09/01/1994	WO1994019015A1 Recombinant fowlpox viruses and uses thereof
09/01/1994	WO1994019014A1 Recombinant fowlpox virus s-fpv-043 and uses thereof
09/01/1994	WO1994018992A1 Cytopathic viruses for therapy and prophylaxis of neoplasia
09/01/1994	WO1993025662A3 Replication of hepatitis c virus genome and identification of virus having high infectivity
09/01/1994	CA2156725A1 Production of high titer helper-free retroviruses by transient transfection
09/01/1994	CA2156423A1 Recombinant fowlpox viruses and uses thereof
08/1994
08/31/1994	EP0612844A2 Expression constructs containing HIV inhibitory antisense and other nucleotide sequences, retroviral vectors and recombinant retroviruses containing same
08/31/1994	EP0612532A2 Canine coronavirus vaccine from feline enteric coronavirus
08/31/1994	EP0612244A1 Endothelin receptor antagonists
08/31/1994	EP0460065B1 A process for the generation of proliferating cd4 lymphocytes
08/30/1994	US5342930 Genetic engineering
08/30/1994	US5342774 Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1
08/30/1994	US5342752 Method of inactivation of viral blood contaminants using acridine deriatives
08/26/1994	CA2116253A1 Expression constructs containing hiv inhibitory antisense and other nucleotide sequences, retroviral vectors and recombinant retroviruses containing same
08/24/1994	EP0611822A2 More complex type retroviruses having mixed type LTR, and uses thereof
08/24/1994	EP0611397A1 Feline leukemia virus vaccines
08/24/1994	EP0611393A1 Replication of hepatitis c virus genome and identification of virus having high infectivity
08/23/1994	CA1331562C Vaccine
08/18/1994	WO1994018569A1 Method for detecting viral compounds using a glycoprotein
08/18/1994	WO1994018311A1 Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines
08/18/1994	WO1994017825A1 Multiple-gene mutants of human immunodeficiency virus (hiv) for vaccine use
08/18/1994	WO1994017813A1 Defective sindbis virus vectors that express toxoplasma gondii p30 antigens
08/18/1994	WO1994006454A3 Inhibitiion of retrovirus infection
08/18/1994	CA2115811A1 A method for in vivo selection of ligand-binding proteins
08/16/1994	US5338683 Genetic engineering, vaccines
08/16/1994	US5338679 Vertebrate poxvoris expression vector under the control of entomopoxvirus spheroidin gene promoter
08/16/1994	US5338674 Process for producing a vaccine for a pathogenic RNA virus and product thereof
08/16/1994	US5338543 Thimerosal inactivated mycoplasma hyopneumoniae vaccine
08/16/1994	CA1331444C Ibdv production in continuous lines
08/10/1994	EP0609305A1 Type c-like human retrovirus linked to multiple sclerosis (ms)
08/10/1994	EP0428656B1 Human cell line lc5 and its use
08/04/1994	WO1994016716A1 Recombinant virus immunotherapy
08/03/1994	CN1090203A Polypeptide vaccine for aftosa and its preparation
08/02/1994	US5334383 Concurrent with colchicine
08/02/1994	CA1331155C Baculovirus transfer vectors

1 ... 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 ... 267